After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Ocular Therapeutix Inc is $1.16B. A total of 1.59 million shares were traded on the day, compared to an average of 1.69M shares.
In the most recent transaction, LINDSTROM RICHARD L MD bought 10,000 shares of OCUL for 6.96 per share on May 08 ’25. After the transaction, the Director now owns 172,704 company shares. In a previous transaction on Feb 24 ’25, Dugel Pravin sold 21,475 shares at 6.87 per share. OCUL shares that the insider owns now total 3,520,318.
Among the insiders who sold shares, Heier Jeffrey S. disposed of 3,061 shares on Feb 24 ’25 at a per-share price of $6.87. This resulted in the Chief Scientific Officer holding 265,998 shares of OCUL after the transaction. In another insider transaction, Kaiser Peter sold 3,009 shares at $6.87 per share on Feb 24 ’25. Company shares held by the Chief Development Officer now total 210,078.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, OCUL has a high of $11.77 and a low of $4.79.
As of this writing, OCUL has an earnings estimate of -$0.35 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.3 per share and a lower estimate of -$0.38.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. OCUL’s latest balance sheet shows that the firm has $164.16M in Cash & Short Term Investments as of fiscal 2021. There were $58.98M in debt and $26.34M in liabilities at the time. Its Book Value Per Share was $1.67, while its Total Shareholder’s Equity was $88.00M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock.
